Connection

Co-Authors

This is a "connection" page, showing publications co-authored by David Cole and Brenda Hoffman.
Connection Strength

0.189
  1. Accurate discrimination of Barrett's esophagus and esophageal adenocarcinoma using a quantitative three-tiered algorithm and multimarker real-time reverse transcription-PCR. Clin Cancer Res. 2005 Mar 15; 11(6):2205-14.
    View in: PubMed
    Score: 0.067
  2. Differentiation of benign from malignant pancreatic masses by endoscopic ultrasound. Ann Surg Oncol. 1997 Dec; 4(8):639-43.
    View in: PubMed
    Score: 0.041
  3. Phase 2 trial of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiation in patients with borderline resectable or unresectable locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 2014 Mar 15; 88(4):837-44.
    View in: PubMed
    Score: 0.031
  4. Accurate discrimination of pancreatic ductal adenocarcinoma and chronic pancreatitis using multimarker expression data and samples obtained by minimally invasive fine needle aspiration. Int J Cancer. 2007 Apr 01; 120(7):1511-7.
    View in: PubMed
    Score: 0.019
  5. Accurate molecular detection of non-small cell lung cancer metastases in mediastinal lymph nodes sampled by endoscopic ultrasound-guided needle aspiration. Chest. 2005 Feb; 127(2):430-7.
    View in: PubMed
    Score: 0.017
  6. Real-time reverse transcription-PCR detects KS1/4 mRNA in mediastinal lymph nodes from patients with non-small cell lung cancer. Clin Chem. 2003 Feb; 49(2):312-5.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.